vs
Side-by-side financial comparison of Agilent Technologies (A) and Celanese Corp (CE). Click either name above to swap in a different company.
Celanese Corp is the larger business by last-quarter revenue ($2.2B vs $1.8B, roughly 1.2× Agilent Technologies). Agilent Technologies runs the higher net margin — 17.0% vs 0.6%, a 16.3% gap on every dollar of revenue. On growth, Agilent Technologies posted the faster year-over-year revenue change (7.0% vs -7.0%). Agilent Technologies produced more free cash flow last quarter ($175.0M vs $168.0M). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs -8.1%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Celanese Corporation, formerly known as Hoechst Celanese, is an American technology and specialty materials company headquartered in Irving, Texas. It is a Fortune 500 corporation. The company is the world's leading producer of acetic acid, producing about 1.95 million tonnes per year, representing approximately 20% of global production. Celanese is also the world's largest producer of vinyl acetate monomer (VAM).
A vs CE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $2.2B |
| Net Profit | $305.0M | $14.0M |
| Gross Margin | 52.6% | 19.1% |
| Operating Margin | 19.6% | 4.0% |
| Net Margin | 17.0% | 0.6% |
| Revenue YoY | 7.0% | -7.0% |
| Net Profit YoY | -4.1% | 100.7% |
| EPS (diluted) | $1.07 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $2.2B | ||
| Q3 25 | $1.7B | $2.4B | ||
| Q2 25 | $1.7B | $2.5B | ||
| Q1 25 | $1.7B | $2.4B | ||
| Q4 24 | $1.7B | $2.4B | ||
| Q3 24 | $1.6B | $2.6B | ||
| Q2 24 | $1.6B | $2.7B |
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $14.0M | ||
| Q3 25 | $336.0M | $-1.4B | ||
| Q2 25 | $215.0M | $199.0M | ||
| Q1 25 | $318.0M | $-21.0M | ||
| Q4 24 | $351.0M | $-1.9B | ||
| Q3 24 | $282.0M | $116.0M | ||
| Q2 24 | $308.0M | $155.0M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | 19.1% | ||
| Q3 25 | 51.1% | 21.5% | ||
| Q2 25 | 51.9% | 21.1% | ||
| Q1 25 | 53.5% | 19.9% | ||
| Q4 24 | 53.9% | 22.7% | ||
| Q3 24 | 54.2% | 23.5% | ||
| Q2 24 | 54.4% | 24.2% |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 4.0% | ||
| Q3 25 | 20.7% | -52.7% | ||
| Q2 25 | 18.0% | 9.2% | ||
| Q1 25 | 22.4% | 7.0% | ||
| Q4 24 | 24.0% | -59.3% | ||
| Q3 24 | 21.1% | 9.4% | ||
| Q2 24 | 23.1% | 9.4% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 0.6% | ||
| Q3 25 | 19.3% | -56.1% | ||
| Q2 25 | 12.9% | 7.9% | ||
| Q1 25 | 18.9% | -0.9% | ||
| Q4 24 | 20.6% | -80.8% | ||
| Q3 24 | 17.9% | 4.4% | ||
| Q2 24 | 19.6% | 5.8% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $0.13 | ||
| Q3 25 | $1.18 | $-12.39 | ||
| Q2 25 | $0.75 | $1.81 | ||
| Q1 25 | $1.11 | $-0.19 | ||
| Q4 24 | $1.23 | $-17.50 | ||
| Q3 24 | $0.97 | $1.06 | ||
| Q2 24 | $1.05 | $1.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | — |
| Total DebtLower is stronger | $3.0B | $11.4B |
| Stockholders' EquityBook value | $6.9B | $4.0B |
| Total Assets | $12.8B | $21.7B |
| Debt / EquityLower = less leverage | 0.44× | 2.81× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.7B | — |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $11.4B | ||
| Q3 25 | $3.4B | $11.7B | ||
| Q2 25 | $3.3B | $12.7B | ||
| Q1 25 | $3.3B | $12.4B | ||
| Q4 24 | $3.3B | $11.1B | ||
| Q3 24 | $2.1B | $11.3B | ||
| Q2 24 | $2.1B | $11.1B |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $4.0B | ||
| Q3 25 | $6.4B | $4.0B | ||
| Q2 25 | $6.1B | $5.3B | ||
| Q1 25 | $6.0B | $5.2B | ||
| Q4 24 | $5.9B | $5.2B | ||
| Q3 24 | $5.9B | $7.3B | ||
| Q2 24 | $6.2B | $7.2B |
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $21.7B | ||
| Q3 25 | $12.2B | $22.2B | ||
| Q2 25 | $12.2B | $23.7B | ||
| Q1 25 | $11.9B | $23.2B | ||
| Q4 24 | $11.8B | $22.9B | ||
| Q3 24 | $11.0B | $25.9B | ||
| Q2 24 | $10.9B | $25.8B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 2.81× | ||
| Q3 25 | 0.53× | 2.95× | ||
| Q2 25 | 0.55× | 2.41× | ||
| Q1 25 | 0.56× | 2.39× | ||
| Q4 24 | 0.57× | 2.14× | ||
| Q3 24 | 0.36× | 1.56× | ||
| Q2 24 | 0.34× | 1.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $252.0M |
| Free Cash FlowOCF − Capex | $175.0M | $168.0M |
| FCF MarginFCF / Revenue | 9.7% | 7.6% |
| Capex IntensityCapex / Revenue | 5.2% | 3.8% |
| Cash ConversionOCF / Net Profit | 0.88× | 18.00× |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $803.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $252.0M | ||
| Q3 25 | $362.0M | $447.0M | ||
| Q2 25 | $221.0M | $410.0M | ||
| Q1 25 | $431.0M | $37.0M | ||
| Q4 24 | $481.0M | $494.0M | ||
| Q3 24 | $452.0M | $79.0M | ||
| Q2 24 | $333.0M | $292.0M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $168.0M | ||
| Q3 25 | $259.0M | $383.0M | ||
| Q2 25 | $107.0M | $317.0M | ||
| Q1 25 | $334.0M | $-65.0M | ||
| Q4 24 | $388.0M | $389.0M | ||
| Q3 24 | $360.0M | $-9.0M | ||
| Q2 24 | $230.0M | $187.0M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 7.6% | ||
| Q3 25 | 14.9% | 15.8% | ||
| Q2 25 | 6.4% | 12.5% | ||
| Q1 25 | 19.9% | -2.7% | ||
| Q4 24 | 22.8% | 16.4% | ||
| Q3 24 | 22.8% | -0.3% | ||
| Q2 24 | 14.6% | 7.1% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 3.8% | ||
| Q3 25 | 5.9% | 2.6% | ||
| Q2 25 | 6.8% | 3.7% | ||
| Q1 25 | 5.8% | 4.3% | ||
| Q4 24 | 5.5% | 4.4% | ||
| Q3 24 | 5.8% | 3.3% | ||
| Q2 24 | 6.5% | 4.0% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 18.00× | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.03× | 2.06× | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | 1.37× | — | ||
| Q3 24 | 1.60× | 0.68× | ||
| Q2 24 | 1.08× | 1.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
CE
| Engineered Materials | $1.3B | 58% |
| Acetyl Chain | $940.0M | 43% |
